CCAP — Crescent Capital Bdc Income Statement
0.000.00%
- $530.84m
- $1.40bn
- $197.36m
- 51
- 88
- 24
- 55
Annual income statement for Crescent Capital Bdc, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 77.1 | 94 | 117 | 184 | 197 |
| Cost of Revenue | |||||
| Gross Profit | 53.4 | 53 | 56.7 | 87.2 | 93.8 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 30.5 | 44.1 | 56.8 | 100 | 107 |
| Operating Profit | 46.6 | 49.9 | 59.9 | 83.8 | 90.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 55.2 | 85.9 | 15.7 | 85.1 | 75.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 54.7 | 83.6 | 15.5 | 83.8 | 73.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 54.7 | 83.6 | 15.5 | 83.8 | 73.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 54.7 | 83.6 | 15.5 | 83.8 | 73.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.11 | 2.94 | 0.503 | 2.33 | 1.99 |
| Dividends per Share | |||||
| Special Dividends per Share |